+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dermatomycoses Drug"

From
Dermatomycoses - Epidemiology Forecast - 2032 - Product Thumbnail Image

Dermatomycoses - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Dermatomycoses - Pipeline Insight, 2024 - Product Thumbnail Image

Dermatomycoses - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Dermatomycoses drugs are a type of dermatological drug used to treat fungal infections of the skin, hair, and nails. These drugs are typically administered topically, either as creams, ointments, or powders, and are often used in combination with other antifungal agents. Common active ingredients in dermatomycoses drugs include clotrimazole, miconazole, terbinafine, and ketoconazole. These drugs are used to treat a variety of fungal infections, including athlete's foot, jock itch, ringworm, and yeast infections. The dermatomycoses drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. These companies include Bayer, Novartis, Pfizer, Merck, and GlaxoSmithKline. Additionally, there are a number of smaller companies that specialize in the production of dermatomycoses drugs, such as Galderma, Mylan, and Perrigo. Show Less Read more